Taiwan FDA registration 2676e1a3776375f95a027dfa394a0d35
Cimosir lupus anticoagulant factor quality plasma
TW: 希摩西爾狼瘡性抗凝血因子品管血漿
Taiwan·Risk Class 2·INSTRUMENTATION LABORATORY CO.·Registered Feb 06, 2013 – Feb 06, 2028ActiveRegistration details
- Analysis ID
- 2676e1a3776375f95a027dfa394a0d35
- Customs Code
- DHA00602453403
Company information
- Manufacturer
- INSTRUMENTATION LABORATORY CO.
- Manufacturer Country
- United States
- Authorized Representative
- Werfen Taiwan Limited
Product details
- Intended Use
- 在IL血液凝固儀器[ACL TOP系列,ACL ELITE/ELITE PRO/8/9/10000,ACL Futura/ACL Advance,ACL Classic(100-7000)]上作為狼瘡性抗凝固因子分析(dRVVT Screen/dRVVT Confirm, LAC Screen/LAC Confirm, Silica Clotting time)的LA品質管制
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.5425 Versatile system for in vitro agglutination studies
- Import Information
- import
Dates and status
- Registration Date
- Feb 06, 2013
- Expiry Date
- Feb 06, 2028
About this record
Access comprehensive regulatory information for Cimosir lupus anticoagulant factor quality plasma in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2676e1a3776375f95a027dfa394a0d35 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices